It's World Antibiotic Awareness Week and NovaVive is doing its part to help address the concern about antibiotic resistance by offering antibiotic alternatives for animals to the veterinary community and livestock/pet owners.
NovaVive Inc. Signs AABEX Animal Health to Provide U.S. Marketing Services
NovaVive Inc. has signed a marketing services agreement with AABEX Animal Health for the U.S.A. AABEX is a new animal health sales and marketing company founded by Mark Hill, a seasoned industry professional from Merial Ltd.
NovaVive Signs a Co-Operation Agreement with Hoken Biotechnology to Register and Market Amplimune™ in Asia
NovaVive and Hoken Biotechnology have committed to work together to introduce Amplimune™ to Asian markets. Hoken will conduct clinical studies to support regulatory submissions and will be our sales and marketing agent.
NovaVive Inc. Announces its Canine Cancer Development Plan
Building on its safe and effective treatment for canine mammary cancer (Immunocidin®), NovaVive is targeting canine hemangiosarcoma, chemotherapy-induced neutropenia, and palliation as new indications.
Belleville, Ontario – Graeme McRae, Founder and Chairman Emeritus of Bioniche Life Sciences Inc., has founded NovaVive Inc., a Belleville, Ontario, Canada-based company that is acquiring and developing specialty, imm...